Delivery Order SPE2DB22D2206-SPE2DB24FFF60
Award Date 1/23/24
Potential Completion Date 1/24/24
Potential Value $7.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,643,171 units of Ondansetron ODT 8 mg tablets in 30-count packages. The $2,239.95 contract has a completion date of February 14, 2024 and was awarded on February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,734.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 8 mg tablets. The contract has a completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,235,087 units of Ondansetron ODT 4 mg tablets. The $4,464.67 contract has an ultimate completion date of April 11, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor and serves as the primary supplier of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,728,753 units of Ondansetron ODT 8 mg tablets. The $3,297.64 contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) valued up...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,635,055 units of the pharmaceutical product Ondansetron ODT 4 MG Tablet 30S. The contract has a potential value of $5,262.72 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,225 units of Ondansetron ODT 4 mg tablets. The $1,261.72 contract has a completion date of January 4, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceutical products and medical supplies to support DLA Troop Support Medical facilities and programs. This delivery order is...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 mg tablets. The $3,437.60 order is to be completed by January 24, 2024. Amerisourcebergen Drug Corp has a history of providing pharmaceutical products, medical supplies, and distribution services to the Department of Defense under various DLA contracts. This delivery order did not utilize a...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $1,915.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,205 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,267,956 units of the pharmaceutical product Ondansetron ODT 8 mg Tablet 30s. The $2,356.79 delivery order is part of a broader indefinite delivery contract between Amerisourcebergen Drug Corp and DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. The award does not...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,533.85 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the Amerisourcebergen Corporation. The contract is for the supply of 4,564,325,614 units of the prescription drug Ondansetron ODT 4 mg Tablet 30s. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025....